Abstract
We report intrathecal use of gadolinium DTPA for MRI of the cerebrospinal fluid (CSF). In two patients with leptomeningeal carcinomatosis, we injected 0.01 mmol gadolinium DTPA into the lateral ventricle via an Ommaya device. Coronal T1-weighted images of the head were obtained at 0.2 T prior to and after injection. There was pronounced enhancement of CSF close to the injection site, allowing good delineation of CSF and surrounding brain tissue. No side effects occurred. MRI with intrathecal administration of highly diluted gadolinium DTPA may be a promising alternative to conventional investigation of CSF-filled cavities using iodinated X-ray contrast media or radionuclides.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 29 April 1996 Accepted: 25 September 1996
Rights and permissions
About this article
Cite this article
Siebner, H., von Einsiedel, H. & Conrad, B. Magnetic resonance ventriculography with gadolinium DTPA: report of two cases. Neuroradiology 39, 418–422 (1997). https://doi.org/10.1007/s002340050436
Issue Date:
DOI: https://doi.org/10.1007/s002340050436